Barriers and facilitators related to leprosy detection in Costa Rica
DOI:
https://doi.org/10.51481/amc.v62i2.1063Keywords:
Keywords : Acute polyarthritis / Leprosy / Systemic disease, barriers to access health services, early diagnosis, qualitative analysis, Costa RicaAbstract
Objective: To analyze barriers and facilitators related to the diagnosis of leprosy in Costa Rica from the perspective of the person with the disease and in the context of everyday life.
Methods: A qualitative exploratory study was carried out from 25 semi-structured interviews, with people with leprosy or with a history of having it, aged between 23 - 88 years, treated in the Costa Rican public health system. From the analysis of the qualitative data, the barriers and facilitators were classified into personal, cultural factors and the offer of health services.
Results: In relation to personal factors, most of the participants reported having no knowledge or awareness prior to the disease. Fear of being stigmatized, intermittent symptoms, feeling good, work and family commitments were perceived as barriers. Among the cultural factors, some religious beliefs were perceived as barriers and the family history of leprosy as a facilitator in terms of seeking care and diagnosis. With respect to health services, timely access to appointments with informed health personnel, telemedicine and family doctors were cited as facilitators.
Conclusions: The main barriers and facilitators described in the results of the study should be considered in order to contribute to the detection and timely treatment of leprosy to cure the disease avoid disability and eliminate transmission.
Downloads
References
Han XY. Detection of the Leprosy Agent Mycobacterium lepromatosis in South America and Europe. Am. J. Trop. Med Hyg. 2017;96:260.
Han XY, Quintanilla M. Diffuse Lepromatous Leprosy Due to Mycobacterium lepromatosis in Quintana Roo, Mexico. J Clin Microbiol. 2015;53:3695-8.
Virk A, Pritt B, Patel R, Uhl JR, Bezalel SA, Gibson LE, et al. Mycobacterium lepromatosis Lepromatous Leprosy in US Citizen Who Traveled to Disease-Endemic Areas. Emerg Infect Dis. 2017;23:1864-6.
Vera-Cabrera L, Escalante-Fuentes W, Ocampo-Garza SS, Ocampo-Candiani J, Molina-Torres CA, Avanzi C, et al. Mycobacterium lepromatosis Infections in Nuevo León, Mexico. J Clin Microbiol. 2015;53:1945-6.
van Hooij A, Tjon Kon Fat EM, Batista da Silva M, Carvalho Bouth R, Cunha Messias AC, Gobbo AR, et al. Evaluation of Immunodiagnostic Tests for Leprosy in Brazil, China and Ethiopia. Sci Rep . 2018;8:17920.
Jaramillo-Antillón O, Espinoza-Aguirre A, Lobo-Philp R. Hansen en Costa Rica: pasado, presente y futuro. Acta Méd. Costarric. 2009; 51:229-35.
Rivera A, Espinoza A. Comportamiento epidemiológico de la lepra en Costa Rica, de 2012 al 2017. RC_UCR-HSJD. 2018;8:6.
Flores Sandí G, Rivera Chavarría AL, Solano Calderón P. TEMA-2017: Enfermedad de Hansen: A propósito de un caso médico-legal. RC_UCR-HSJD. 2017;7:6.
Valiente Hernández Y, Hernández Moya M. Costos directos e indirectos del diagnóstico y tratamiento de pacientes con lepra. MEDISAN. 2016;20:299-305.
Gomez L, Rivera A, Vidal Y, Bilbao J, Kasang C, Parisi S, et al. Factors associated with the delay of diagnosis of leprosy in north-eastern Colombia: a quantitative analysis. Trop Med Int Health. 2018;23:193-8.
Marmará D, Marmará V, Hubbard G. Health beliefs, illness perceptions and determinants of breast screening uptake in Malta: a cross-sectional survey. BMC public health. 2017;17:416-.
Shojaei S, Farhadloo R, Aein A, Vahedian M. Effects of the Health Belief Model (HBM)-Based Educational Program on the Nutritional Knowledge and Behaviors of CABG Patients. J Tehran Heart Cent. . 2016;11:181-6.
Shabibi P, Zavareh MSA, Sayehmiri K, Qorbani M, Safari O, Rastegarimehr B, et al. Effect of educational intervention based on the Health Belief Model on promoting self-care behaviors of type-2 diabetes patients. Electron Physician. 2017; 9:5960-8.
Tabah EN, Nsagha DS, Bissek A-CZ-K, Njamnshi TN, Njih IN-N, Pluschke G, et al. Community knowledge, perceptions and attitudes regarding leprosy in rural Cameroon: The case of Ekondotiti and Mbonge health districts in the South-west Region. PLoS Negl Trop Dis. 2018; 12:e0006233.
Tabah EN, Nsagha DS, Bissek A-CZ-K, Bratschi MW, Njamnshi TN, Plushke G, et al. The Burden of Leprosy in Cameroon: Fifteen Years into the Post-elimination Era. PLoS Negl Trop Dis. 2016;10:e0005012.
Nsagha DS, Bissek A-CZK, Nsagha SM, Njunda AL, Assob JCN, Tabah EN, et al. Social stigma as an epidemiological determinant for leprosy elimination in Cameroon. J Public Health Afr J. 2011;2:e10-e.
Sermrittirong S, Van Brakel WH. Stigma in leprosy: concepts, causes and determinants. Lepr Rev. 2014;85:36-47.
Ebenso B, Newell J, Emmel N, Adeyemi G, Ola B. Changing stigmatisation of leprosy: an exploratory, qualitative life course study in Western Nigeria. BMJ Global Health. 2019;4:e001250.
Singh GP. Psychosocial aspects of Hansen's disease (leprosy). Indian Dermatol OnlineJ . 2012;3:166-70.
Price VG. Factors preventing early case detection for women affected by leprosy: a review of the literature. Glob Health Action. 2017;10:1360550.
Atre SR, Rangan SG, Shetty VP, Gaikwad N, Mistry NF. Perceptions, health seeking behaviour and access to diagnosis and treatment initiation among previously undetected leprosy cases in rural Maharashtra, India. Lepr Rev. 2011;82:222-34.
Peters RMH, Dadun, Lusli M, Miranda-Galarza B, van Brakel WH, Zweekhorst MBM, et al. The Meaning of Leprosy and Everyday Experiences: An Exploration in Cirebon, Indonesia. J Trop Med. 2013; 2013:10.
Correia JC, Golay A, Lachat S, Singh SB, Manandhar V, Jha N, et al. ""If you will counsel properly with love, they will listen"": A qualitative analysis of leprosy affected patients' educational needs and caregiver perceptions in Nepal. PLOS ONE. 2019;14:e0210955.
Marinho FD, Avellar LZ, Souza LGS, Nardi SMT, Coutinho GC. Leprosy: meanings and experiences among adolescents with the disease and their family members. Cad. Bras.Ter. Ocup. 2018;26:837-48.
Singh S, Sinha AK, Banerjee BG, Jaswal N. Knowledge, Beliefs and Perception of Leprosy. Disability, CBR & Inclusive Development. 2013;23:67-75.
Lazar M, Davenport L. Barriers to Health Care Access for Low Income Families: A Review of Literature. J Community Health Nurs. 2018;35:28-37.
Rich EC, Burke W, Heaton CJ, Haga S, Pinsky L, Short MP, et al. Reconsidering the family history in primary care. J Gen Intern Med. 2004; 19:273-80.
Thakkar S, Patel SV. Clinical profile of leprosy patients: a prospective study. Indian J Dermatol. 2014;59:158-62.
Chen XS, Ye GY, Jiang C, Li WZ, Bian J, Wang H, et al. An investigation of attitudes, beliefs and behaviour of leprosy patients, family members and PHC workers towards multidrug therapy in Yangzhou and Dongtai Districts of China. Lepr Rev. 1997;68:155-61.
Huang H-T, Kuo Y-M, Wang S-R, Wang C-F, Tsai C-H. Structural Factors Affecting Health Examination Behavioral Intention. Int J Environ Res Public Health. 2016; 13:395; 13:395-.
Joseph G, Burke NJ, Tuason N, Barker JC, Pasick RJ. Perceived susceptibility to illness and perceived benefits of preventive care: an exploration of behavioral theory constructs in a transcultural context. Health Educ. Behav. 2009; 36:71S-90S.
Maimela E, Van Geertruyden J-P, Alberts M, Modjadji SEP, Meulemans H, Fraeyman J, et al. The perceptions and perspectives of patients and health care providers on chronic diseases management in rural South Africa: a qualitative study. BMC Health Serv Res. 2015;15:143-.
Watchmaker L, Watchmaker J, DeLeon D, Stavert R. Leprosy Diagnosed Via Teledermatology in a U. S. Urban Academic Health Center Highlights Potential Benefits and a Pitfall of Existing Telemedicine Services. Telemed J E Health. 2018; 25:1-3.
Wijeratne MP, Ostbye T. Knowledge, Attitudes and Practices relating to Leprosy among Public Health Care Providers in Colombo, Sri Lanka. Lepr Rev. 2017;88:75-84.
Downloads
Published
Versions
- 2020-09-09 (2)
- 2020-06-01 (1)
Issue
Section
License
Copyright (c) 2020 Acta Médica Costarricense
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Los autores que publican en la revista Acta Médica Costarricense pueden distribuir, copiar, remezclar, retocar, leer, descargar, imprimir, buscar y crear a partir de su obra de modo no comercial, indicando los créditos a la revista y sus autores y compartir su obra en las mismas condiciones. Para ello se aplica la licencia Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional(CC BY-NC-SA 4.0)
